Prof. James Spicer

Professor of Experimental Cancer Medicine, King’s College London, and Consultant in Medical Oncology, Guy’s and St. Thomas’ Hospitals London. He holds a PhD in Cancer Biology from the Institute of Cancer Research in London, and a degree in biochemistry from the University of Oxford. Our Principle Investigator for our planned PoC trial.

Professor James Spicer
Principle Investigator & Clinical Advisor


Dr Jonathan Milner

Funding & Growth Advisor


Jonathan Milner, Founder of Abcam plc, is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 60 companies and has assisted three technology companies to IPO on the London AIM Stock exchange.

Dr Tony de Fougerolles

Scientific & Partnerships Advisor


With over 20 years of biotech R&D experience building out drug pipelines and helping drive several multi-billion-dollar companies from start-up, Tony is one of Biotech’s most successful leaders. Before joining Evox Therapeutics Ltd as CEO, Tony was CSO of Ablynx, Moderna Therapeutics, Alnylam and Tolerx Inc. 

Professor Mark Lowdell


Clinical Immunopathologist, Professor of Cell and Tissue Therapy at UCL. Leading pioneer in cell therapies, including co-founding INmune Bio, Achilles Therapeutics, Cell Medica

Professor Mark Lowdell

Scientific & Clinical Advisor

Mark Lowdell 220221.png